The primary mechanisms of action include: Appetite suppression GLP-1 agonists act on receptors in the hypothalamus to increase satiety and reduce hunger signals [21] Delayed gastric emptying slowing the rate at which food leaves the stomach, prolonging feelings of fullness Improved insulin secretion enhancing glucose-dependent insulin release from pancreatic beta cells Reduced glucagon secretion decreasing hepatic glucose production Whilst GLP-1 medications do not directly increase basal metabolic rate, they influence energy balance through reduced caloric intake
10.1016/j.phrs.2019.104554 [DOI] [PubMed] [Google Scholar] 127.Katalinic L, Krtalic B, Jelakovic B, Basic-Jukic N
Nausea is typically most pronounced during dose initiation and escalation, generally improving over 24 weeks as physiologic adaptation occurs
Do GLP-1 medications help with perimenopausal symptoms beyond weight loss
Earlier this year, Teva Pharmaceuticals had launched an authorized generic version of Victoza in the U.S
Diabetes Obes Metab 2020;22:24519